# A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.

> **NCT04134845** · PHASE2,PHASE3 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 68 (actual)

## Conditions studied

- Ventricular Tachycardia

## Interventions

- **DRUG:** Dantrolene/Ryanodex
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04134845
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-21
- **Primary completion:** 2025-05-29
- **Final completion:** 2025-08-29
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04134845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04134845, "A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04134845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*